Abstract: 582 ATTAINMENT OF SINGLE/DUAL TREATMENT LEVELS FOR LDL-C AND NON-HDL-C, APOB, OR HS-CRP IN PATIENTS WITH METABOLIC SYNDROME (MS): EZETIMIBE(E)/SIMVASTATIN(S) VS ATORVASTATIN(A)

✍ Scribed by Ballantyne, C; Grundy, S; Hsueh, W; Parving, H; Robinson, J; Rosen, J; Lin, J; Lowe, R; Shah, A; Tomassini, J; Tershakovec, A

• Book ID: 118637178
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 233 KB
• Volume: 10
• Category: Article
• ISSN: 1567-5688
• DOI: 10.1016/s1567-5688(09)70339-3